TD Private Client Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
TD Private Client Wealth's AMGN Position: Q2 2026 in Review
TD Private Client Wealth reduced its Amgen (AMGN) stake by 3.2% in Q2 2026, selling an estimated $197K and leaving 17,457 shares worth $6.32M. The position accounts for 0.12% of the portfolio, ranked #113.
TD Private Client Wealth first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $8.82M in Q3 2023. 3,148 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- TD Private Client Wealth held 17,457 shares of Amgen worth $6.32M as of Q2 2026.
- TD Private Client Wealth sold 576 Amgen shares in Q2 2026, an estimated $197K.
- Amgen made up 0.12% of TD Private Client Wealth's portfolio in Q2 2026, its #113 holding.
- TD Private Client Wealth first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
- TD Private Client Wealth's Amgen position peaked at $8.82M in Q3 2023.
- 3,148 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.